<?xml version='1.0' encoding='utf-8'?>
<document id="28109684"><sentence text="Increase in the systemic exposure of primary metabolites of Midazolam in rat arising from CYP inhibition or hepatic dysfunction."><entity charOffset="60-69" id="DDI-PubMed.28109684.s1.e0" text="Midazolam" /></sentence><sentence text="The main purpose of this study is to demonstrate the possibility of increase in the systemic exposure of drug metabolites by CYP-inhibition or acute hepatitis" /><sentence text=" Midazolam (MDZ) was used as a model substrate of CYP3A and 1-aminobenzotriazole (ABT) was used as a CYP-inhibitor"><entity charOffset="1-10" id="DDI-PubMed.28109684.s3.e0" text="Midazolam" /><entity charOffset="12-15" id="DDI-PubMed.28109684.s3.e1" text="MDZ" /><entity charOffset="50-55" id="DDI-PubMed.28109684.s3.e2" text="CYP3A" /><entity charOffset="60-80" id="DDI-PubMed.28109684.s3.e3" text="1-aminobenzotriazole" /><entity charOffset="82-85" id="DDI-PubMed.28109684.s3.e4" text="ABT" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e0" e2="DDI-PubMed.28109684.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e0" e2="DDI-PubMed.28109684.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e0" e2="DDI-PubMed.28109684.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e0" e2="DDI-PubMed.28109684.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e0" e2="DDI-PubMed.28109684.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e1" e2="DDI-PubMed.28109684.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e1" e2="DDI-PubMed.28109684.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e1" e2="DDI-PubMed.28109684.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e1" e2="DDI-PubMed.28109684.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e2" e2="DDI-PubMed.28109684.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e2" e2="DDI-PubMed.28109684.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e2" e2="DDI-PubMed.28109684.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e3" e2="DDI-PubMed.28109684.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28109684.s3.e3" e2="DDI-PubMed.28109684.s3.e4" /></sentence><sentence text=" After oral pretreatment with ABT, MDZ was intravenously injected to rats and the plasma profiles of MDZ and its primary metabolites, 1'-hydroxy MDZ and 4-hydroxy MDZ, were observed"><entity charOffset="134-148" id="DDI-PubMed.28109684.s4.e0" text="1'-hydroxy MDZ" /><entity charOffset="153-166" id="DDI-PubMed.28109684.s4.e1" text="4-hydroxy MDZ" /><entity charOffset="35-47" id="DDI-PubMed.28109684.s4.e2" text="MDZ" /><entity charOffset="101-113" id="DDI-PubMed.28109684.s4.e3" text="MDZ" /><entity charOffset="145-157" id="DDI-PubMed.28109684.s4.e4" text="MDZ" /><entity charOffset="163-175" id="DDI-PubMed.28109684.s4.e5" text="MDZ" /><entity charOffset="30-42" id="DDI-PubMed.28109684.s4.e6" text="ABT" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e6" e2="DDI-PubMed.28109684.s4.e6" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e6" e2="DDI-PubMed.28109684.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e6" e2="DDI-PubMed.28109684.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e6" e2="DDI-PubMed.28109684.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e6" e2="DDI-PubMed.28109684.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e6" e2="DDI-PubMed.28109684.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e6" e2="DDI-PubMed.28109684.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e2" e2="DDI-PubMed.28109684.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e2" e2="DDI-PubMed.28109684.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e2" e2="DDI-PubMed.28109684.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e2" e2="DDI-PubMed.28109684.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e2" e2="DDI-PubMed.28109684.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e2" e2="DDI-PubMed.28109684.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e3" e2="DDI-PubMed.28109684.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e3" e2="DDI-PubMed.28109684.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e3" e2="DDI-PubMed.28109684.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e3" e2="DDI-PubMed.28109684.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e3" e2="DDI-PubMed.28109684.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e0" e2="DDI-PubMed.28109684.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e0" e2="DDI-PubMed.28109684.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e0" e2="DDI-PubMed.28109684.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e0" e2="DDI-PubMed.28109684.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e4" e2="DDI-PubMed.28109684.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e4" e2="DDI-PubMed.28109684.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e4" e2="DDI-PubMed.28109684.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e1" e2="DDI-PubMed.28109684.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s4.e1" e2="DDI-PubMed.28109684.s4.e5" /></sentence><sentence text=" In the ABT-pretreatment rats, plasma AUCs of both metabolites were much larger than those in control rats, demonstrating a higher systemic exposure of metabolites under CYP-inhibited condition"><entity charOffset="8-10" id="DDI-PubMed.28109684.s5.e0" text="ABT" /></sentence><sentence text=" Furthermore, kinetic analysis revealed that the amount of both metabolites entered into the systemic circulation increased significantly (about 5-times)" /><sentence text=" Increases in the systemic exposure of the primary metabolites of MDZ were also observed in the acute hepatitis rats induced by CCl4-pretreatment"><entity charOffset="66-68" id="DDI-PubMed.28109684.s7.e0" text="MDZ" /></sentence><sentence text=" As underlying mechanisms, it was speculated that ABT inhibited the subsequent metabolism of primary metabolites of MDZ in the hepatocytes and enhanced their release to the systemic circulation"><entity charOffset="116-118" id="DDI-PubMed.28109684.s8.e0" text="MDZ" /><entity charOffset="50-52" id="DDI-PubMed.28109684.s8.e1" text="ABT" /><pair ddi="false" e1="DDI-PubMed.28109684.s8.e1" e2="DDI-PubMed.28109684.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28109684.s8.e1" e2="DDI-PubMed.28109684.s8.e0" /></sentence><sentence text=" InÂ vitro study with rat liver microsomes supported this speculation" /><sentence text=" In conclusion, this study showed the complexity of PK profiles of drug metabolites, which might lead to new aspects on their safety issue" /><sentence text="" /></document>